Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.

Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, Parnell LD, Tucker KL, Ordovas JM.

Circulation. 2006 May 2;113(17):2062-70. Epub 2006 Apr 24.

2.

Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.

Lai CQ, Demissie S, Cupples LA, Zhu Y, Adiconis X, Parnell LD, Corella D, Ordovas JM.

J Lipid Res. 2004 Nov;45(11):2096-105. Epub 2004 Sep 1.

3.

APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.

Sánchez-Moreno C, Ordovás JM, Smith CE, Baraza JC, Lee YC, Garaulet M.

J Nutr. 2011 Mar;141(3):380-5. doi: 10.3945/jn.110.130344. Epub 2011 Jan 5.

4.

Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.

Kim JY, Kim OY, Paik JK, Lee SH, Lee JH.

J Clin Lipidol. 2013 Mar-Apr;7(2):94-101. doi: 10.1016/j.jacl.2012.06.002. Epub 2012 Jun 28.

PMID:
23415427
5.

APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study.

Corella D, Lai CQ, Demissie S, Cupples LA, Manning AK, Tucker KL, Ordovas JM.

J Mol Med (Berl). 2007 Feb;85(2):119-28. Epub 2007 Jan 9.

PMID:
17211608
6.

Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.

Moreno-Luna R, Perez-Jimenez F, Marin C, Perez-Martinez P, Gomez P, Jimenez-Gomez Y, Delgado-Lista J, Moreno JA, Tanaka T, Ordovas JM, Lopez-Miranda J.

J Clin Endocrinol Metab. 2007 Jun;92(6):2280-5. Epub 2007 Mar 13.

PMID:
17356049
9.

APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study.

Talmud PJ, Martin S, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Humphries SE, Syvänne M.

J Lipid Res. 2004 Apr;45(4):750-6. Epub 2004 Jan 16.

10.

The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.

Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas JM, Lee JH.

Clin Chim Acta. 2009 Apr;402(1-2):83-7. doi: 10.1016/j.cca.2008.12.024. Epub 2008 Dec 31.

11.

Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease.

Park JY, Paik JK, Kim OY, Chae JS, Jang Y, Lee JH.

J Lipid Res. 2010 Nov;51(11):3281-8. doi: 10.1194/jlr.M010330. Epub 2010 Aug 27.

12.

Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduces fasting triglycerides and enhances apolipoprotein A-V levels in non-diabetic subjects with hypertriglyceridemia.

Ahn HY, Kim M, Chae JS, Ahn YT, Sim JH, Choi ID, Lee SH, Lee JH.

Atherosclerosis. 2015 Aug;241(2):649-56. doi: 10.1016/j.atherosclerosis.2015.06.030. Epub 2015 Jun 18.

PMID:
26117402
13.

The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE study.

Hubacek JA, Peasey A, Kubinova R, Pikhart H, Bobak M.

Nutr Metab Cardiovasc Dis. 2014 Mar;24(3):243-7. doi: 10.1016/j.numecd.2013.08.008. Epub 2013 Oct 9.

14.

Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study.

Tai ES, Corella D, Demissie S, Cupples LA, Coltell O, Schaefer EJ, Tucker KL, Ordovas JM; Framingham heart study.

J Nutr. 2005 Mar;135(3):397-403.

PMID:
15735069
15.

Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.

Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, Joglekar CV, Fall CH, Mohankrishna P, Wilkin TJ, Metcalf BS, Weedon MN, Frayling TM, Hattersley AT.

BMC Med Genet. 2006 Oct 10;7:76.

16.

Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.

van der Vleuten GM, Isaacs A, Zeng WW, ter Avest E, Talmud PJ, Dallinga-Thie GM, van Duijn CM, Stalenhoef AF, de Graaf J.

Biochim Biophys Acta. 2007 Jan;1772(1):81-8. Epub 2006 Oct 26.

17.

Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.

Komurcu-Bayrak E, Onat A, Poda M, Humphries SE, Palmen J, Guclu F, Can G, Erginel-Unaltuna N.

Clin Chem Lab Med. 2008;46(6):778-84. doi: 10.1515/CCLM.2008.161.

PMID:
18601598
18.

Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.

Mar R, Pajukanta P, Allayee H, Groenendijk M, Dallinga-Thie G, Krauss RM, Sinsheimer JS, Cantor RM, de Bruin TW, Lusis AJ.

Circ Res. 2004 Apr 16;94(7):993-9. Epub 2004 Mar 4.

19.

Postprandial remnant-like lipoproteins in hypertriglyceridemia.

Ooi TC, Cousins M, Ooi DS, Steiner G, Uffelman KD, Nakajima K, Simo IE.

J Clin Endocrinol Metab. 2001 Jul;86(7):3134-42.

PMID:
11443178
20.

Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.

Cole TG, Patsch W, Kuisk I, Gonen B, Schonfeld G.

J Clin Endocrinol Metab. 1983 Jun;56(6):1108-15.

PMID:
6841553

Supplemental Content

Support Center